Cargando…
The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
Following natural dengue virus (DENV) infection, humans produce some antibodies that recognize only the serotype of infection (type specific) and others that cross-react with all four serotypes (cross-reactive). Recent studies with human antibodies indicate that type-specific antibodies at high conc...
Autores principales: | Smith, Scott A., de Alwis, A. Ruklanthi, Kose, Nurgun, Harris, Eva, Ibarra, Kristie D., Kahle, Kristen M., Pfaff, Jennifer M., Xiang, Xiaoxiao, Doranz, Benjamin J., de Silva, Aravinda M., Austin, S. Kyle, Sukupolvi-Petty, Soila, Diamond, Michael S., Crowe, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870244/ https://www.ncbi.nlm.nih.gov/pubmed/24255124 http://dx.doi.org/10.1128/mBio.00873-13 |
Ejemplares similares
-
Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
por: de Alwis, Ruklanthi, et al.
Publicado: (2011) -
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
por: de Alwis, Ruklanthi, et al.
Publicado: (2011) -
Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
por: Kafai, Natasha M., et al.
Publicado: (2022) -
Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
por: Williams, Katherine L., et al.
Publicado: (2013) -
Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
por: Williams, Katherine L., et al.
Publicado: (2013)